BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21323623)

  • 1. Evaluation of two HbA1c point-of-care analyzers.
    Sánchez-Mora C; S Rodríguez-Oliva M; Fernández-Riejos P; Mateo J; Polo-Padillo J; Goberna R; Sánchez-Margalet V
    Clin Chem Lab Med; 2011 Apr; 49(4):653-7. PubMed ID: 21323623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.
    Saxton AT; Miranda JJ; Ortiz EJ; Pan W
    Ann Glob Health; 2018 Nov; 84(4):618-624. PubMed ID: 30779508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method.
    Petersen JR; Omoruyi FO; Mohammad AA; Shea TJ; Okorodudu AO; Ju H
    Clin Chim Acta; 2010 Dec; 411(23-24):2062-6. PubMed ID: 20832393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.
    Wood JR; Kaminski BM; Kollman C; Beck RW; Hall CA; Yun JP; Cengiz E; Haller MJ; Hassan K; Klingensmith GJ; Tamborlane WV
    J Diabetes Sci Technol; 2012 Mar; 6(2):380-6. PubMed ID: 22538150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus.
    Torregrosa ME; Molina J; Argente CR; Ena J
    Endocrinol Nutr; 2015 Dec; 62(10):478-84. PubMed ID: 26531840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the Quality of HbA1c Determination by Using Commutable Specimens With IFCC-Assigned Values.
    Zhou R; Gao ZQ; Tong Q; Zuo C; Song ZX; Wang W; Wang QT
    Lab Med; 2017 May; 48(2):148-153. PubMed ID: 28371852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing analytical variation between point-of-care and laboratory HbA1c testing.
    Malkani S; Korpi-Steiner N; Rao LV
    J Diabetes; 2013 Jun; 5(2):192-6. PubMed ID: 23035661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of point-of-care analysers for C-reactive protein, lipid studies and glycated haemoglobin.
    Li B; Kumar A; Finlay C; van Drimmelen M; Barnes E; Southby S; Florkowski C
    Pathology; 2023 Dec; 55(7):989-999. PubMed ID: 37778963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA
    Dubach IL; Christ ER; Diem P
    Prim Care Diabetes; 2019 Dec; 13(6):583-587. PubMed ID: 31175054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a HbA1c point-of-care analyzer.
    Menéndez-Valladares P; Fernández-Riejos P; Sánchez-Mora C; Pérez-Pérez A; Sánchez-Margalet V; González-Rodríguez C
    Clin Biochem; 2015 Jul; 48(10-11):686-9. PubMed ID: 25835152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of two glycated hemoglobin immunoassays.
    Guadalupe Vargas M; Pazmiño Gomez BJ; Vera Lorenti FE; Álvarez Condo GM; Rodas Neira EI; Veron D; Fernández Veron M; Cercado AG; Bahar B; Tufro A; Veron D
    Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):297-303. PubMed ID: 31859182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the performance of urine albumin, creatinine and albumin-creatinine ratio assay on two POCT analyzers relative to a central laboratory method.
    Omoruyi FO; Mustafa GM; Okorodudu AO; Petersen JR
    Clin Chim Acta; 2012 Mar; 413(5-6):625-9. PubMed ID: 22212624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of HbA1c analyzers: D-10, Variant II Turbo, Cobas Integra 800, and Afinion AS100].
    Lee JY; Hong KS; Cho SE
    Korean J Lab Med; 2010 Aug; 30(4):345-50. PubMed ID: 20805705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance of the Axis-Shield Afinion for hemoglobin A1c measurement: impact of lot number.
    Dupuy AM; Badiou S; Elong-Bertard C; Bargnoux AS; Cristol JP
    Clin Lab; 2014; 60(3):369-76. PubMed ID: 24697111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Three Hemoglobin A1c Point-of-Care Instruments.
    Criel M; Jonckheere S; Langlois M
    Clin Lab; 2016; 62(3):285-91. PubMed ID: 27156315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers.
    Yeo CP; Tan CH; Jacob E
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):373-6. PubMed ID: 19487414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care testing of HbA1C is traceable to IFCC reference method by external calibration.
    Zhou R; Tong Q; Zuo C; Song ZX; Ma HA; Yue YH; Zhang R; Wang QT
    Clin Chim Acta; 2014 Jun; 433():249-53. PubMed ID: 24675057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin A1c: comparing performance of two point of care devices with laboratory analyser.
    Wan Mohd Zin RM; Ahmad Kamil ZI; Tuan Soh TR; Embong M; Wan Mohamud WN
    BMC Res Notes; 2013 Dec; 6():540. PubMed ID: 24344903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of the Arkray Adams HA-8160 HbA1c analyser.
    Thevarajah TM; Nani N; Chew YY
    Malays J Pathol; 2008 Dec; 30(2):81-6. PubMed ID: 19291916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.
    Lenters-Westra E; Slingerland RJ
    Clin Chem; 2010 Jan; 56(1):44-52. PubMed ID: 19926777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.